AtriCure, Inc.
ATRC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001323885
In the last 90 days, AtriCure, Inc. insiders filed 0 open-market purchases and 10 sales; 251 institutions reported holding it in 13F filings for Q2 2026, worth $1.48B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $3.32M in total
- 10
- 13F holdersQ2 2026, +29 vs. previous quarter
- 251
- 13F valueReported value at the end of Q2 2026
- $1.48B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ATRC, Q2 2026
No superinvestor reported holding ATRC at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by AtriCure, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 (view filing)5:00 PM ET | Sep 23 | 1 day | Privitera SalvatoreChief Technical Officer | SSale | −4.52K | $60.00 | −$271.1K | −3.1%142.7K after | 10b5-1 |
| Sep 14, 2026 (view filing)5:44 PM ET | Sep 11 | 3 days | Groves Regina EDirector | SSale | −5.31K | $54.22 | −$288.1K | −13.3%34.5K after | |
| Sep 10, 2026 (view filing)9:18 AM ET | Sep 8 | 2 days | Privitera SalvatoreChief Technical Officer | SSale | −3.66K | $55.00 | −$201.1K | −2.4%147.3K after | 10b5-1 |
| Sep 4, 2026 (view filing)7:39 AM ET | Sep 2 | 2 days | Privitera SalvatoreChief Technical Officer | SSale | −7.76K | $52.50 | −$407.6K | −4.9%150.9K after | 10b5-1 |
| Aug 26, 2026 (view filing)6:50 AM ET | Aug 24 | 2 days | Dahlquist Karl S.Chief Legal Officer | SSale | −9.37K | $48.89 | −$458.1K | −9.7%87.3K after | |
| Aug 7, 2026 (view filing)9:18 AM ET | Aug 5 | 2 days | Prange KarenDirector | SSale | −3.56K | $38.80 | −$138.3K | −13.5%22.8K after | |
| Aug 7, 2026 (view filing)9:18 AM ET | Aug 5 | 2 days | Yuen MaggieDirector | SSale | −3.50K | $38.42 | −$134.5K | −20.0%14.0K after | |
| Jul 30, 2026 (view filing)4:57 PM ET | Jul 28 | 2 days | Doraiswamy VinayakChief Scientific Officer | SSale | −6.00K | $38.88 | −$233.3K | −6.5%86.5K after | |
| Jul 30, 2026 (view filing)4:57 PM ET | Jul 28 | 2 days | Wehrwein SvenDirector | SSale | −25.0K | $37.84 | −$946.0K | −38.2%40.5K after | |
| Jul 30, 2026 (view filing)4:57 PM ET | Jul 29 | 1 day | Noznesky Justin JChief Mktg & Strategy Officer | SSale | −6.18K | $38.80 | −$239.9K | −5.8%100.2K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in AtriCure, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,474,548 | $125.2M | 0.00% | +431,867+10.7% | Added |
| Wellington Management Group LLP | 3,495,603 | $97.8M | 0.02% | +113,048+3.3% | Added |
| Vanguard Portfolio Management LLC | 3,127,195 | $87.5M | 0.00% | +424,563+15.7% | Added |
| Hood River Capital Management LLC | 2,905,299 | $81.3M | 0.59% | −212,246−6.8% | Reduced |
| Alliancebernstein L.P. | 2,768,365 | $79.0M | 0.03% | −490,507−15.1% | Reduced |
| Vanguard Capital Management LLC | 2,190,413 | $61.3M | 0.00% | +34,649+1.6% | Added |
| Nomura Asset Management International Inc. | 1,734,279 | $48.5M | 0.07% | −70,648−3.9% | Reduced |
| Goldman Sachs Group Inc | 1,597,988 | $44.7M | 0.00% | −69,178−4.1% | Reduced |
| State Street Corp | 1,389,989 | $38.9M | 0.00% | +87,827+6.7% | Added |
| Marshall Wace, LLP | 1,333,904 | $37.3M | 0.03% | −133,620−9.1% | Reduced |